You will automatically be redirected in 10 seconds. Or, you can click the link below:

https://www.streetinsider.com/Corporate+News/Immunogen+%28IMGN%29+Announces+EU+Acceptance+of+Marketing+Authorization+Application+for+Mirvetuximab+Soravtansine/22322195.html